Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- JMA Proposes Step-wise Integration of Health Insurance Programs
December 2, 2002
- CMIC: Annual Sales, Profits Increase Sharply
December 2, 2002
- Korosho to Create Database to Identify Similar Drugs
December 2, 2002
- ARKRAY to Push Healthcare Products Business
December 2, 2002
- Major Wholesalers Report Large Increases in Profits
December 2, 2002
- REGULATORY NEWS IN BRIEF
December 2, 2002
- Meet the Leaders (12)
December 2, 2002
- Kuraya Sanseido: Sales Up 3.8%, Profits Up 254.6%
December 2, 2002
- Olympus: Medical Systems Group Sales Up 9.3% to \127 Bil.
December 2, 2002
- Santen: Sales Up 6.1%, but Profits Down 41.6%
December 2, 2002
- Suzuken: Expansion of Pharmacy Market Drives Sales, Profits
December 2, 2002
- MEDICAL DEVICE NEWS IN BRIEF
December 2, 2002
- Kyorin: New Products Drive Increases in 1st-half Sales, Profits
December 2, 2002
- Azwell: "Painful Reforms" Bring Return to Profitability
December 2, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 2, 2002
- Mochida: NHI Price Cuts Affect Semiannual Sales, Profits
December 2, 2002
- Toho: Cost-cutting, Higher Margins Boost Sales, Profits
December 2, 2002
- Meiji Seika Discovers Enzymes Inactivating Abnormal Prion Protein
December 2, 2002
- Rohto: Profits Jump Despite Modest Increase in Sales
December 2, 2002
- Tanabe Seiyaku to Co-develop Altana's Roflumilast
December 2, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…